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Hormones are both growth stimulatory and growth inhibitory in utero [1] . They act as environmental and maturational signals in regulating the accretion and differentiation of fetal tissues during late gestation, thereby ensuring that fetal development is appropriate for the nutrient supply and optimal for survival at birth. They can also alter the morphological and functional characteristics of the placenta, the main source of nutrients for fetal growth [2] . The main growth regulatory hormones are insulin, the insulin-like growth factors (IGFs), the thyroid hormones, glucocorticoids and, possibly, leptin ( fig. 1 ). These hormones interact extensively in the control of fetal growth and development, both metabolically and via regulation of their own cellular bioavailability.
Insulin is essential for normal fetal growth. Its deficiency in utero leads to symmetrical intrauterine growth retardation (IUGR) but has little effect on placental phenotype or fetal maturation during the prepartum period (table 1) . Insulin stimulates cellular uptake of glucose and amino acids, which increases their availability for tissue accretion. Thyroid hormones also stimulate fetal growth via anabolic actions on fetal metabolism. They regulate oxidative metabolism and, hence, the availability of energy for cell growth [3] . These hormones also have effects on tissue differentiation at key developmental milestones and during the prepartum period that are essential for neonatal survival [1] . Deficient fetal production of thyroid hormones, therefore, leads to an asymmetrical IUGR with adverse consequences particularly for skeletal-muscular development in species with poor placental permeability to these hormones (table 1) . In part, the growth stimulatory actions of insulin and the thyroid hormones are mediated by the IGFs which have similar anabolic effects on fetal metabolism [4] . The IGFs, IGF-1 and IGF-2, are also both mitogens, which regulate the cell cycle and the balance between cell proliferation and differentiation in relation to the prevailing nutritional and endocrine conditions (table 1) . These growth factors also have an important role in regulating the development and nutrient transfer capacity of the placenta [2] . In general, growth stimulatory hormones, therefore, have anabolic effects on fetal metabolism and act as nutrient sensors in matching the fetal growth rate to the availability of nutrients in utero [1, 3] .
In contrast, glucocorticoids are growth inhibitory in utero but essential for tissue differentiation in preparation for delivery. Their deficiency during late gestation leads to increased fetal bodyweight while, conversely, cortisol infusion before term leads to IUGR in fetal sheep (table  1) . Glucocorticoids are responsible for the natural decrease in growth rate towards term and probably contribute to IUGR during adverse conditions that raise fetal glucocorticoid concentrations [5] . They also impair placental growth, nutrient transport and endocrine function with consequences for the availability of nutrients and growth factors required for tissue accretion. In addition, they activate glucogenesis, proteolysis Data from references [1] [2] [3] [4] [5] . CRL = Crown rump length; SNS = sympathetic nervous system; CNS = central nervous system. and amino acid oxidation, which further restricts accretion of new tissue [5] . Furthermore, glucocorticoids stimulate the morphological and functional differentiation of a wide range of fetal tissues. These actions of the glucocorticoids are both direct via changes in gene expression and indirect through alterations in the activity of endocrine systems like the IGFs, leptin and the thyroid hormones ( fig. 1 ). Indeed, leptin may act to counterbalance the maturational effects of glucocorticoids in some tissues during late gestation. Growth inhibitory hormones are, therefore, generally catabolic and limit tissue accretion yet may stimulate tissue differentiation to maximize chances of survival. Thus, complex interactions exist between hormones in regulating the fetal growth ( fig. 1 ), which can have phenotypical consequences long after birth [1] .
